Comparing HLA shared epitopes in French Caucasian patients with scleroderma. - Wikidata - wikimedia - TriplyDB

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

http://www.wikidata.org/entity/Q34277474

about

HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.Pathogenesis of Systemic Sclerosis.Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis.Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.

P2860

Q35629254-B866FAB0-EF3C-4E05-AD3D-16089766195F Q35693212-33D1771A-7143-49CB-89A5-9AF311CE2432 Q36063970-078C0992-29A2-4D3D-92E7-35DFC0EC161C Q37260460-ADCB4242-4828-4ACB-917B-71D6FE57A6B2 Q37686401-0AEED7F4-643B-4FA0-83BD-3F388BE60C71 Q46463646-D1E7C6E3-E759-4AF7-BCDF-FA980A638272

P2860

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

http://www.wikidata.org/entity/Q34277474

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@ast

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@en

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@nl

type

label

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@ast

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@en

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@nl

prefLabel

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@ast

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@en

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@nl

P1433

Q34277474-3B4A7DCA-9233-4714-9618-98533BFF6E68

P1476

Q34277474-0126F3AE-1CDF-481B-A864-BD6C54891E49

P2093

Q34277474-0DDB1065-8A58-4C21-A2DC-B515F23A3BBF

Q34277474-23FC2DCE-F15C-421B-8AC2-926CA3B4E40F

Q34277474-3DCB69D4-601F-454F-BD88-C358E3385CA0

Q34277474-4B7E3534-98AF-440E-BC0A-B5F3FC735DDD

Q34277474-4E91F920-6108-4120-90C5-719627750460

Q34277474-5B3986A2-9398-4F59-8AD7-63BD385584D0

Q34277474-79019A22-4A0E-4647-B69D-5B23DB64C1F1

Q34277474-8B310B93-8025-424D-85DE-C4FD0EEE47A6

Q34277474-8E949FBC-6BBB-4F4E-8E54-554561C5FA7F

Q34277474-9A82278E-B6C5-4876-974A-311A729574E1

P2860

Q34277474-054EC7DA-7A31-42B2-A41D-491CA624675D

Q34277474-17A7B615-986F-407D-AEC2-098A343F08D0

Q34277474-226DC266-3D5B-4D26-B904-120D536BE936

Q34277474-241EA9F6-8DC8-43A7-B4C1-B811AA7D4EF1

Q34277474-4D38463D-7671-4BF7-BF33-260174B763CB

Q34277474-56E3F360-12CA-4F7E-955F-677C45320EF1

Q34277474-6497EA9F-6B3F-4909-BC96-D988E849CD4F

Q34277474-708D105A-3A2A-451B-A4AD-2056500C8979

Q34277474-7EB9BC8E-DC8E-42F3-9F77-31FEBB8671AC

Q34277474-91F1D98A-CBEB-4A45-AC85-6827D8E341F3

P304

Q34277474-024D9F20-4E2F-4ABE-996A-8A3B71831641

P31

Q34277474-9F839BF9-0C49-42F9-BC1F-C670EEBF643E

P356

Q34277474-DD96A950-63A4-4DF6-81B0-5BF42020F1A9

P407

Q34277474-4F446610-0667-4AD4-8192-565A79F47A99

P433

Q34277474-C388A674-835D-474D-83D1-613C98C57C79

P478

Q34277474-9A71AFFC-D123-4167-A462-1D19CA2B96E5

P50

Q34277474-43745C78-ACAC-4877-961E-695AF2CED683

Q34277474-78AE5EDA-9A3A-4C2C-9470-F386645857ED

P577

Q34277474-1554F6E2-5C75-46B9-B7F9-2DFA6546D3E7

P5875

Q34277474-EC4ABF23-C607-4F6B-9AD4-4BA410780B8D

P698

Q34277474-F57870DF-D3BC-4643-B989-334A8D2B96E7

P932

Q34277474-2868134A-FB72-402C-A4F4-F000377F5690

P356

JOURNAL.PONE.0036870

P1433

P1476

Comparing HLA shared epitopes in French Caucasian patients with scleroderma.

@en

P2093

Brigitte Granel

http://www.w3.org/2001/XMLSchema#string

Dominique Farge-Bancel

http://www.w3.org/2001/XMLSchema#string

Doua F Azzouz

http://www.w3.org/2001/XMLSchema#string

Isabelle Fajardy

http://www.w3.org/2001/XMLSchema#string

Jean Cabane

http://www.w3.org/2001/XMLSchema#string

Jean Robert Harlé

http://www.w3.org/2001/XMLSchema#string

Jean Roudier

http://www.w3.org/2001/XMLSchema#string

Justyna M Rak

http://www.w3.org/2001/XMLSchema#string

Kiet Phong Tiev

http://www.w3.org/2001/XMLSchema#string

Marielle Martin

http://www.w3.org/2001/XMLSchema#string

P2860

The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)

Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis

The clinical relevance of autoantibodies in scleroderma

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses

Statistics review 8: Qualitative data - tests of association

The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families

Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation

Informed consent in human experimentation before the Nuremberg code.

P304

e36870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0036870

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Lambert

P577

2012-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225030072

http://www.w3.org/2001/XMLSchema#string

P698

22615829

http://www.w3.org/2001/XMLSchema#string

P932

3352938

http://www.w3.org/2001/XMLSchema#string